Provention Bio (PRVB) Peer Comparison

$24.98

$0.00 (0.00%)

As on 27-Apr-2023 09:30EDT

Market cap

$2,375 Mln

Revenue (TTM)

$13 Mln

P/E Ratio

--

P/B Ratio

5.3

Div. Yield

0 %

Edit

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Market cap ($ Mln)	2,375	17
Revenue ($ Mln)	13	48
Net Profit ($ Mln)	-113.57	-23.29
Net Margin (%)	-818.77	-51.56
RoE (%)	133.43	-89.47
Price to Earnings	--	--
Price-To-Book	5.31	0.66

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Operating Revenue	12.90	48.34
Cost of Revenue	0.51	38.58
Gross Profit	12.38	9.76
Operating Expenses	140.54	30.16
Operating Profit (EBIT)	-128.16	-20.40
Other Income	--	--
Profit before Tax	-126.96	-23.26
Provision for Tax	-13.39	0.03
Profit after Tax (Net Income)	-113.57	-23.29
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities ($ Mln)

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Shareholder's Funds	121.85	17.80
Minority Interest	--	--
Non-Current Liabilities	24.62	5.51
Current Liabilities	90.39	39.30
Total Liabilities	236.86	62.61

Assets ($ Mln)

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Non-Current Assets	62.21	14.16
Current Assets	174.65	48.45
Total Assets	236.86	62.61
Total Debt*	23.91	25.08
Net Current Assets	84.26	9.15

Cashflow ($ Mln)

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Cash From Operating Activities	-75.41	-12.69
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	129.38	3.37
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
ROCE (%)	155.86	-45.22
ROE (%)	133.43	-89.47
ROA (%)	-60.98	-34.29
EBIT Margin (%)	--	--
Net Margin (%)	-880.69	-48.18
Cash Profit Margin (%)	--	--

Growth Ratios

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Revenue Growth (%)	8.24	0.31
EBIT Growth (%)	--	--
Net Profit Growth (%)	0.76	31.30
EPS Growth (%)	0.17	0.48
Book Value Growth (%)	--	--

Valuation Ratios

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Price / Earnings	-6.98	-0.30
Price / Book Value	6.51	0.40
Dividend Yield (%)	--	--
EV/EBITDA	-5.23	-0.95
Market Cap ($ Cr)	--	--

Solvency Ratios

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Debt to Equity	0.20	1.41
Short term debt to equity ratio	--	1.10
Current Ratio	1.93	1.23
Quick Ratio	1.92	1.04
Interest Coverage	-123.59	-53.41

Operating Efficiency Ratios

	Provention Bio (PRVB)	Chembio Diagnostics (CEMI)
Debtors to sales (%)	10.54	38.73
Asset Turnover	0.07	0.71
Receivable days	38.49	113.96
Inventory Days	878.17	97.69
Payable days	3,676.40	52.49
Cash Conversion Cycle	-2,759.74	159.15

Annual
Quarterly